Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.

MLA

Mateos, Maria V., et al. “Effect of Prior Treatments on Selinexor, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma.” Journal of Hematology & Oncology, vol. 14, no. 1, Apr. 2021, p. 59. EBSCOhost, https://doi.org/10.1186/s13045-021-01071-9.

APA

Mateos, M. V., Gavriatopoulou, M., Facon, T., Auner, H. W., Leleu, X., Hájek, R., Dimopoulos, M. A., Delimpasi, S., Simonova, M., Špička, I., Pour, L., Kriachok, I., Pylypenko, H., Doronin, V., Usenko, G., Benjamin, R., Dolai, T. K., Sinha, D. K., Venner, C. P., … Grosicki, S. (2021). Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. Journal of Hematology & Oncology, 14(1), 59. https://doi.org/10.1186/s13045-021-01071-9

Chicago

Mateos, Maria V, Maria Gavriatopoulou, Thierry Facon, Holger W Auner, Xavier Leleu, Roman Hájek, Meletios A Dimopoulos, et al. 2021. “Effect of Prior Treatments on Selinexor, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma.” Journal of Hematology & Oncology 14 (1): 59. doi:10.1186/s13045-021-01071-9.